Beyond GLP-1 Agonists: Plant-Derived Bioactive Compounds as Adjunctive Strategies for Obesity Management
Nutrients · 2026
DOI: 10.3390/nu18142266 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Aurelian Vasile und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Agriculture, University of Agronomic Sciences and Veterinary Medicine of Bucharest, 59 Marasti Blvd, District 1, 011464 Bucharest, Romania. Hauptthemen laut MEDLINE: Obesity, Phytochemicals, Glucagon-Like Peptide-1 Receptor Agonists, Obesity Management. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Ministry of Research, Innovation and Digitization.
Abstract (Originalsprache)
Background
Obesity has reached epidemic proportions, affecting over one billion adults worldwide. While incretin-based pharmacotherapies—GLP-1 receptor agonists (semaglutide) and dual GIP/GLP-1 agonists (tirzepatide)—have transformed obesity treatment, their use remains limited by high costs, adverse effects, restricted eligibility, and rapid weight regain following discontinuation. Plant-derived bioactive compounds represent a promising complementary approach to address these gaps.
Objective
This narrative review synthesizes clinical trial evidence on plant-based interventions for obesity management and examines their potential role as adjunctive strategies before, during, and after incretin-based pharmacotherapy.
Methods
A literature search was conducted in PubMed, Scopus, and Web of Science (2012–2026), prioritizing randomized controlled trials in adults with overweight or obesity reporting at least one obesity-related metabolic outcome. Sixty-one studies were selected and classified by efficacy tier based on the magnitude and breadth of observed clinical effects.
Results
The strongest evidence supports polyphenol-rich dietary patterns, particularly the green-Mediterranean diet, producing significant reductions in body weight, visceral fat, and cardiometabolic risk markers. Specific extracts—including curcumin, bergamot polyphenols, and Lippia citriodora/Hibiscus sabdariffa combinations—demonstrated clinically meaningful metabolic improvements. Isolated high-dose resveratrol and several single-compound interventions showed limited benefit, largely attributable to poor bioavailability. The most effective compounds acted through multiple pathways, including AMPK activation, gut microbiota modulation, and appetite hormone regulation.
Conclusions
Plant-derived bioactive compounds offer a safe, accessible adjunctive strategy for obesity management, particularly relevant for patients ineligible for or discontinuing pharmacotherapy. Future trials should directly evaluate plant-polyphenol combinations alongside GLP-1 receptor agonists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Agriculture, University of Agronomic Sciences and Veterinary Medicine of Bucharest, 59 Marasti Blvd, District 1, 011464 Bucharest, Romania.
- Faculty of Biotechnology, University of Agronomic Sciences and Veterinary Medicine of Bucharest, 59 Marasti Blvd, District 1, 011464 Bucharest, Romania.
- National Research-Development Institute for Animal Biology and Nutrition (IBNA), 1 Calea Bucuresti, 077015 Balotesti, Romania.
- Faculty of Animal Production Engineering and Management, University of Agronomic Sciences and Veterinary Medicine of Bucharest, 59 Marasti Blvd, District 1, 011464 Bucharest, Romania.
- Faculty of Land Reclamation and Environmental Engineering, University of Agronomic Sciences and Veterinary Medicine of Bucharest, 59 Marasti Blvd, District 1, 011464 Bucharest, Romania.
ORCID-Profile: Andrei Cristian Anghel, Teodor Ioan Trasca, Alina Ortan
Förderung
- Ministry of Education
- Ministry of Research, Innovation and Digitization
Zitieren
APA
Vasile, A., Anghel, A. C., Trasca, T. I., & Ortan, A. (2026). Beyond GLP-1 Agonists: Plant-Derived Bioactive Compounds as Adjunctive Strategies for Obesity Management. Nutrients. https://doi.org/10.3390/nu18142266
Vancouver
Vasile A, Anghel AC, Trasca TI, Ortan A. Beyond GLP-1 Agonists: Plant-Derived Bioactive Compounds as Adjunctive Strategies for Obesity Management. Nutrients. 2026. doi:10.3390/nu18142266
BibTeX
@article{Vasile2026,
author = {Vasile, Aurelian and Anghel, Andrei Cristian and Trasca, Teodor Ioan and Ortan, Alina},
title = {Beyond GLP-1 Agonists: Plant-Derived Bioactive Compounds as Adjunctive Strategies for Obesity Management},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18142266}
}
EUVIMED